Can I Take Turmeric / Curcumin with Testosterone Enanthate?

Does turmeric interact with testosterone enanthate?

Testosterone enanthate injection is labeled for primary and hypogonadotropic hypogonadism in men, for delayed puberty in carefully selected boys, and secondarily for metastatic breast cancer in postmenopausal women [2]. Turmeric is sold as an over-the-counter dietary supplement, and curcumin is not an FDA-approved drug treatment for any condition [5]. This is a prescription androgen alongside an over-the-counter botanical, and the label's drug interactions section names oral anticoagulants, antidiabetic drugs and insulin, ACTH and corticosteroids, and oxyphenbutazone [2].

What the enanthate label says about clotting and blood counts

The testosterone enanthate label lists, under adverse reactions, suppression of clotting factors II, V, VII and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia [2]. Its drug interactions section calls for close monitoring of people taking oral anticoagulants, especially when an androgen is started or stopped, and notes that C-17 substituted testosterone derivatives such as methandrostenolone have been reported to decrease the anticoagulant requirement [2].

That is a label-documented interaction with prescription anticoagulants. It says nothing about curcumin.

The blood-count side is better quantified. In a dose-response study, 60 men aged 60 to 75 and 61 men aged 19 to 35 received a monthly GnRH agonist plus weekly testosterone enanthate at 25, 50, 125, 300 or 600 mg for 20 weeks; hemoglobin and hematocrit rose in a linear, dose-dependent way (P<0.0001), and the rise was larger in older men [10]. A network meta-analysis of 29 placebo-controlled trials (3,393 men) put the mean hematocrit increase at 4.0% (95% CI 2.9 to 5.1) for intramuscular enanthate/cypionate versus placebo, compared with 4.3% for oral undecanoate, 3.0% for gel, 1.6% for intramuscular undecanoate and 1.4% for patch [1]. A retrospective single-center review of 178 hypogonadal men followed for 3 years found erythrocytosis (hematocrit above 50%) in 66.7% of men on injectable testosterone versus 12.8% on gels; the injection group was younger and had a higher baseline hematocrit, and the study was not randomized [11].

What curcumin does to platelets

In rats, 7 days of curcumin at 100 mg/kg raised warfarin exposure about 1.6-fold and clopidogrel's carboxylic acid metabolite about 1.61-fold, with no change in prothrombin time or platelet aggregation [12]. A separate rat study found reduced platelet aggregation with Curcuma oil, a different turmeric preparation, and a mild effect on bleeding time; the coagulation measures reported in that study (prothrombin time, thrombin time and aPTT) were unchanged [6]. A 2017 review of curcuminoid drug interactions found the data, largely in vitro and animal, insufficient to judge clinical interactions, and identified only one clinical trial showing a significant alteration of drug levels [7].

No controlled human study was found that measured bleeding outcomes with curcumin, so a clinical bleeding risk has not been established.

Does curcumin change how the body handles testosterone?

Testosterone product labels describe inactivation as mainly hepatic, with most of a dose excreted in urine as glucuronic and sulfuric acid conjugates. Curcumin inhibited human recombinant CYP3A4 (IC50 16.3 micromolar) and CYP2C9 (IC50 4.3 micromolar) in a laboratory study; whether that affects testosterone enanthate in people is unknown [13].

The human test of those enzymes came out flat. In a randomized, placebo-controlled six-way crossover, 8 healthy volunteers took 4 g of curcuminoids plus 24 mg piperine four times over 2 days. Plasma Cmax, AUC, clearance, half-life and metabolite levels of midazolam (a CYP3A probe), flurbiprofen (CYP2C9) and paracetamol (UGT and SULT) were unchanged, and there was no change in midazolam sedation or EEG effect [3]. Free curcuminoid concentrations in plasma stayed below the assay's detection limit [3]. That was short-term use in 8 people, which limits how far the result can be extended to a high-dose product taken for months.

Does piperine (black pepper extract) change the picture?

Partly, but through piperine itself rather than curcumin. Twenty milligrams of piperine daily for 7 days raised propranolol and theophylline exposure in 6 healthy subjects per group [8], and a single 20 mg dose raised steady-state phenytoin AUC and Cmax in 20 patients with epilepsy taking 150 to 200 mg twice daily [9].

The famous 2000% figure for curcumin bioavailability comes from a 1998 study of 2 g curcumin with 20 mg piperine [14]. Later work still found free curcuminoids below detection when piperine was included [3], and a 2026 USP review reports that piperine at typical product doses (about 5 to 20 mg) did not meaningfully change free or total curcuminoid levels [15]. Formulation appears to matter more than piperine: in a 24-person crossover, 250 mg of a proprietary curcumin formulation reached 101 times the Cmax and 99 times the AUC of 1,900 mg of 95% turmeric extract [16].

The liver is turmeric's documented risk

The US Drug-Induced Liver Injury Network published 10 adjudicated turmeric cases enrolled between 2004 and 2022, all since 2011 and 6 since 2017. Eight were women, median age was 56 (range 35 to 71), injury was hepatocellular in 9 and mixed in 1, five patients were hospitalized and one died of acute liver failure. Latency was 1 to 4 months, turmeric was confirmed in all 7 products tested, 3 of those also contained piperine, and 7 of the 10 patients carried HLA-B*35:01 (allele frequency 0.450 versus 0.056 to 0.069 in controls) [4]. Italian phytovigilance described 7 Tuscan cases, all with high-bioavailability, high-dose curcumin/curcuminoid products and positive dechallenge in most, plus 23 published cases [17]. The 2026 USP review recommends a label caution that liver problems have been reported very rarely, and that abdominal pain, dark urine or jaundice call for stopping the product and seeking care [15].

Not all liver data point the same way. A meta-analysis of 31 randomized trials found turmeric/curcumin lowered ALT by 4.09 U/L (95% CI -6.49 to -1.70) and AST by 3.81 U/L (95% CI -5.71 to -1.91) but not GGT, on low or very low quality evidence that the authors said does not ensure clinical benefit [18].

The enanthate label has its own liver lines: cholestatic jaundice and altered liver function tests among adverse reactions, and peliosis hepatis and hepatic neoplasms including hepatocellular carcinoma with prolonged use of high doses of androgens [2].

What to watch for on this combination

The enanthate label says testosterone can increase blood pressure, that blood pressure should be monitored periodically especially in men with hypertension, and that testosterone products are not recommended in uncontrolled hypertension [2]. Polycythemia is listed as an adverse reaction, and the Endocrine Society 2018 guideline recommends monitoring symptoms, serum testosterone, hematocrit and prostate cancer risk during the first year of therapy [19]. On the supplement side, the signal worth knowing is the liver caution above [15]; human bleeding outcomes with curcumin have not been established, and the animal and laboratory platelet findings are not evidence that curcumin causes bruising in people [12][7].